Chemours Co (CC)
Return on equity (ROE)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 87,000 | 69,000 | 116,000 | -330,000 | -237,000 | -308,000 | -88,000 | 489,000 | 578,000 | 908,000 | 882,000 | 747,000 | 609,000 | 395,000 | 257,000 | 215,000 | 219,000 | -117,000 | -117,000 | -45,000 |
| Total stockholders’ equity | US$ in thousands | 604,000 | 657,000 | 723,000 | 752,000 | 737,000 | 755,000 | 808,000 | 1,227,000 | 1,107,000 | 1,284,000 | 1,214,000 | 1,166,000 | 1,081,000 | 998,000 | 898,000 | 850,000 | 813,000 | 732,000 | 657,000 | 655,000 |
| ROE | 14.40% | 10.50% | 16.04% | -43.88% | -32.16% | -40.79% | -10.89% | 39.85% | 52.21% | 70.72% | 72.65% | 64.07% | 56.34% | 39.58% | 28.62% | 25.29% | 26.94% | -15.98% | -17.81% | -6.87% |
December 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $87,000K ÷ $604,000K
= 14.40%
Chemours Co's return on equity (ROE) has fluctuated considerably over the given time period. Initially, the company's ROE was negative, indicating that it was not generating profits efficiently relative to its shareholders' equity. However, a significant improvement was seen in the later quarters of 2020 and throughout 2021, with ROE values exceeding 25% and peaking at 72.65% in June 2022.
Subsequently, the ROE decreased sharply in the following quarters of 2023, with negative values indicating potential financial challenges or decreased profitability relative to equity. The latter part of 2024 saw a slight recovery in ROE, reaching values around 10-14.4%, suggesting some improvement in profitability relative to shareholders' equity.
Overall, the fluctuating trend in ROE for Chemours Co indicates periods of both strong and weak financial performance in terms of generating profits from the shareholders' equity invested in the company. Further analysis of the company's financial and operational performance would be necessary to understand the drivers behind these fluctuations in ROE.
Peer comparison
Dec 31, 2024